The role of ETS2 as a tumor suppressor is also supported by studies showing that PCa with TMPRSS2-ERG fusions generated through the deletion of a region containing ETS2 among other genes, represent a more aggressive and hormone-refractory disease [18,20]. This evidence concerns the gene ETS2 and posterior cortical atrophy.